NEW YORK – Roche announced Tuesday its Accu-Check SugarView app, a blood glucose monitor designed to help non-insulin-dependent patients with type 2 diabetes manage their condition between doctors' visits, received the CE mark.
NEW YORK – Roche announced Tuesday its Accu-Check SugarView app, a blood glucose monitor designed to help non-insulin-dependent patients with type 2 diabetes manage their condition between doctors' visits, received the CE mark.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.